IL20 and non-small cell lung carcinoma: IL-20RA has been previously linked to anti-angiogenic effects in NSCLC, and restoration of IL20 signaling through IL20RA was shown to downregulate VEGF expression (Tessema et al., 2008; Baird et al., 2011).